FROM IDEA TO DRUG MOLECULE IN DAYS Trademark

Trademark Overview

On Thursday, July 17, 2025, a trademark application was filed for FROM IDEA TO DRUG MOLECULE IN DAYS with the United States Patent and Trademark Office. The USPTO has given the FROM IDEA TO DRUG MOLECULE IN DAYS trademark a serial number of 99288735. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, July 8, 2026. This trademark is owned by Pauling, Inc.. The FROM IDEA TO DRUG MOLECULE IN DAYS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research; Consulting services in the field of biotechnology
from idea to drug molecule in days

General Information

Serial Number99288735
Word MarkFROM IDEA TO DRUG MOLECULE IN DAYS
Filing DateThursday, July 17, 2025
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, July 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2026

Trademark Statements

Goods and ServicesBiotechnology research; Consulting services in the field of biotechnology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 17, 2025
Primary Code042
First Use Anywhere DateFriday, February 13, 2026
First Use In Commerce DateFriday, February 13, 2026

Trademark Owner History

Party NamePauling, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02109
US
Party NamePauling, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02109
US

Trademark Events

Event DateEvent Description
Thursday, July 17, 2025NEW APPLICATION ENTERED
Thursday, July 17, 2025APPLICATION FILING RECEIPT MAILED
Sunday, November 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 4, 2025ASSIGNED TO EXAMINER
Monday, December 8, 2025NON-FINAL ACTION WRITTEN
Monday, December 8, 2025NON-FINAL ACTION E-MAILED
Monday, December 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 20, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 20, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 20, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 23, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 11, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 17, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 17, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2026NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2026TEAS STATEMENT OF USE RECEIVED
Tuesday, April 21, 2026USE AMENDMENT FILED
Tuesday, July 7, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 8, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 8, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

days molecule drug idea from biotechnology field services consulting research